RIGL vs. CRM

Last updated Jun 3, 2026

RIGL (Rigel Pharmaceuticals, Inc.) and CRM (salesforce.com, inc.) are both stocks. RIGL operates in Biotechnology (Healthcare), while CRM operates in Software - Application (Technology). Over the past 10 years, RIGL returned 1.65%/yr vs 9.46%/yr for CRM. At a 0.28 correlation, their price movements are largely independent.

Performance

RIGL vs. CRM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rigel Pharmaceuticals, Inc. (RIGL) and salesforce.com, inc. (CRM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RIGL achieves a -29.91% return, which is significantly lower than CRM's -24.00% return. Over the past 10 years, RIGL has underperformed CRM with an annualized return of 1.65%, while CRM has yielded a comparatively higher 9.46% annualized return.

RIGL

• 1D: 0.54%
• 1M: 2.11%
• YTD: -29.91%
• 6M: -32.40%
• 1Y: 48.98%
• 3Y*: 28.95%
• 5Y*: -4.61%
• 10Y*: 1.65%

CRM

• 1D: -4.18%
• 1M: 9.26%
• YTD: -24.00%
• 6M: -14.08%
• 1Y: -22.66%
• 3Y*: -1.47%
• 5Y*: -2.46%
• 10Y*: 9.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RIGL vs. CRM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RIGL Rigel Pharmaceuticals, Inc.	-29.91%	154.64%	16.00%	-3.33%	-43.40%	-24.29%	63.55%	-6.96%	-40.72%	63.03%
CRM salesforce.com, inc.	-24.00%	-20.25%	27.76%	98.46%	-47.83%	14.20%	36.82%	18.74%	33.98%	49.33%

Correlation

The correlation between RIGL and CRM is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.24
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Jun 24, 2004	0.28

The correlation between RIGL and CRM shifts across timeframes, from 0.09 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap RIGL : $590.97M CRM : $174.93B
EPS RIGL : $19.21 CRM : $8.59
PE Ratio RIGL : 1.56 CRM : 23.37
PEG Ratio RIGL : 0.00 CRM : 0.05
PS Ratio RIGL : 1.90 CRM : 4.38
PB Ratio RIGL : 1.48 CRM : 5.11
Total Revenue (TTM) RIGL : $299.77M CRM : $42.83B
Gross Profit (TTM) RIGL : $279.95M CRM : $33.25B
EBITDA (TTM) RIGL : $125.80M CRM : $12.32B

Return for Risk

RIGL vs. CRM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RIGL

RIGL Risk / Return Rank: 63
RIGL Sharpe Ratio Rank: 63
RIGL Sortino Ratio Rank: 66
RIGL Omega Ratio Rank: 64
RIGL Calmar Ratio Rank: 63
RIGL Martin Ratio Rank: 60

CRM

CRM Risk / Return Rank: 16
CRM Sharpe Ratio Rank: 15
CRM Sortino Ratio Rank: 16
CRM Omega Ratio Rank: 16
CRM Calmar Ratio Rank: 19
CRM Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RIGL vs. CRM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and salesforce.com, inc. (CRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RIGL	CRM	Difference
Sharpe ratio Return per unit of total volatility	0.70	-0.61	+1.31
Sortino ratio Return per unit of downside risk	1.55	-0.68	+2.23
Omega ratio Gain probability vs. loss probability	1.19	0.92	+0.27
Calmar ratio Return relative to maximum drawdown	1.13	-0.60	+1.73
Martin ratio Return relative to average drawdown	2.02	-1.18	+3.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RIGL vs. CRM - Sharpe Ratio Comparison

The current RIGL Sharpe Ratio is 0.70, which is higher than the CRM Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of RIGL and CRM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RIGL	CRM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.70	-0.61	+1.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	-0.07	+0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.02	0.27	-0.25
Sharpe Ratio (All Time) Calculated using the full available price history	-0.13	0.46	-0.59

Drawdowns

RIGL vs. CRM - Drawdown Comparison

The maximum RIGL drawdown since its inception was -99.37%, which is greater than CRM's maximum drawdown of -70.50%. Use the drawdown chart below to compare losses from any high point for RIGL and CRM.

Drawdown Indicators

	RIGL	CRM	Difference
Max Drawdown Largest peak-to-trough decline	-99.37%	-70.50%	-28.87%
Max Drawdown (1Y) Largest decline over 1 year	-50.08%	-39.46%	-10.62%
Max Drawdown (3Y) Largest decline over 3 years	-57.75%	-54.70%	-3.05%
Max Drawdown (5Y) Largest decline over 5 years	-85.24%	-58.62%	-26.62%
Max Drawdown (10Y) Largest decline over 10 years	-86.40%	-58.62%	-27.78%
Current Drawdown Current decline from peak	-97.19%	-44.85%	-52.34%
Average Drawdown Average peak-to-trough decline	-90.91%	-16.10%	-74.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.87%	20.10%	+7.77%

Volatility

RIGL vs. CRM - Volatility Comparison

Rigel Pharmaceuticals, Inc. (RIGL) has a higher volatility of 19.95% compared to salesforce.com, inc. (CRM) at 16.38%. This indicates that RIGL's price experiences larger fluctuations and is considered to be riskier than CRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RIGL	CRM	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.95%	16.38%	+3.57%
Volatility (6M) Calculated over the trailing 6-month period	39.84%	31.57%	+8.27%
Volatility (1Y) Calculated over the trailing 1-year period	70.01%	37.58%	+32.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.52%	36.96%	+48.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	82.84%	35.31%	+47.53%

Dividends

RIGL vs. CRM - Dividend Comparison

RIGL has not paid dividends to shareholders, while CRM's dividend yield for the trailing twelve months is around 0.84%.

Position	TTM	2025	2024
CRM salesforce.com, inc.	0.84%	0.63%	0.48%
RIGL Rigel Pharmaceuticals, Inc.	0.00%	0.00%	0.00%

Financials

RIGL vs. CRM - Profitability Comparison

The chart below illustrates the profitability comparison between Rigel Pharmaceuticals, Inc. and salesforce.com, inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RIGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.

CRM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, salesforce.com, inc. reported a gross profit of 8.56B and revenue of 11.13B. Therefore, the gross margin over that period was 76.9%.

RIGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.

CRM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, salesforce.com, inc. reported an operating income of 2.35B and revenue of 11.13B, resulting in an operating margin of 21.1%.

RIGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.

CRM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, salesforce.com, inc. reported a net income of 2.11B and revenue of 11.13B, resulting in a net margin of 18.9%.

Frequently Asked Questions

Can I hold both RIGL and CRM in my portfolio?

RIGL and CRM have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RIGL or CRM?

RIGL has higher volatility (19.95%) compared to CRM (16.38%). In terms of maximum drawdown, RIGL dropped -99.37% vs CRM's -70.50%.

Which has better risk-adjusted returns?

RIGL currently has the higher Sharpe Ratio (0.70 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.